Annual CFI
$10.69 M
+$74.81 M+116.67%
December 31, 2023
Summary
- As of February 7, 2025, OBIO annual cash flow from investing activities is $10.69 million, with the most recent change of +$74.81 million (+116.67%) on December 31, 2023.
- During the last 3 years, OBIO annual CFI has fallen by -$16.28 million (-60.37%).
- OBIO annual CFI is now -60.37% below its all-time high of $26.97 million, reached on December 31, 2020.
Performance
OBIO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$557.00 K
-$9.87 M-94.66%
September 30, 2024
Summary
- As of February 7, 2025, OBIO quarterly cash flow from investing activities is $557.00 thousand, with the most recent change of -$9.87 million (-94.66%) on September 30, 2024.
- Over the past year, OBIO quarterly CFI has dropped by -$12.39 million (-95.70%).
- OBIO quarterly CFI is now -98.32% below its all-time high of $33.15 million, reached on December 31, 2023.
Performance
OBIO Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$49.99 M
-$12.39 M-19.86%
September 30, 2024
Summary
- As of February 7, 2025, OBIO TTM cash flow from investing activities is $49.99 million, with the most recent change of -$12.39 million (-19.86%) on September 30, 2024.
- Over the past year, OBIO TTM CFI has increased by +$135.83 million (+158.24%).
- OBIO TTM CFI is now -19.86% below its all-time high of $62.38 million, reached on June 30, 2024.
Performance
OBIO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
OBIO Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +116.7% | -95.7% | +158.2% |
| 3 y3 years | -60.4% | +100.9% | +178.0% |
| 5 y5 years | -60.4% | +100.9% | +178.0% |
OBIO Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -17.9% | +116.7% | -98.3% | +100.9% | -19.9% | +146.5% |
| 5 y | 5-year | -60.4% | +116.7% | -98.3% | +100.9% | -19.9% | +146.5% |
| alltime | all time | -60.4% | +116.7% | -98.3% | +100.9% | -19.9% | +146.5% |
Orchestra BioMed Holdings Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $557.00 K(-94.7%) | $49.99 M(-19.9%) |
| Jun 2024 | - | $10.42 M(+77.9%) | $62.38 M(+3.8%) |
| Mar 2024 | - | $5.86 M(-82.3%) | $60.08 M(+462.2%) |
| Dec 2023 | $10.69 M | $33.15 M(+156.1%) | $10.69 M(-112.4%) |
| Sep 2023 | - | $12.95 M(+59.5%) | -$85.84 M(-13.3%) |
| Jun 2023 | - | $8.12 M(-118.6%) | -$99.01 M(-8.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | -$43.53 M(-31.3%) | -$107.60 M(+67.8%) |
| Dec 2022 | -$64.12 M(-592.6%) | -$63.38 M(>+9900.0%) | -$64.12 M(+8507.0%) |
| Sep 2022 | - | -$224.00 K(-52.7%) | -$745.00 K(+43.0%) |
| Jun 2022 | - | -$474.00 K(+908.5%) | -$521.00 K(+1008.5%) |
| Mar 2022 | - | -$47.00 K | -$47.00 K |
| Dec 2021 | $13.02 M(-51.7%) | - | - |
| Dec 2020 | $26.97 M | - | - |
FAQ
- What is Orchestra BioMed Holdings annual cash flow from investing activities?
- What is the all time high annual CFI for Orchestra BioMed Holdings?
- What is Orchestra BioMed Holdings annual CFI year-on-year change?
- What is Orchestra BioMed Holdings quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Orchestra BioMed Holdings?
- What is Orchestra BioMed Holdings quarterly CFI year-on-year change?
- What is Orchestra BioMed Holdings TTM cash flow from investing activities?
- What is the all time high TTM CFI for Orchestra BioMed Holdings?
- What is Orchestra BioMed Holdings TTM CFI year-on-year change?
What is Orchestra BioMed Holdings annual cash flow from investing activities?
The current annual CFI of OBIO is $10.69 M
What is the all time high annual CFI for Orchestra BioMed Holdings?
Orchestra BioMed Holdings all-time high annual cash flow from investing activities is $26.97 M
What is Orchestra BioMed Holdings annual CFI year-on-year change?
Over the past year, OBIO annual cash flow from investing activities has changed by +$74.81 M (+116.67%)
What is Orchestra BioMed Holdings quarterly cash flow from investing activities?
The current quarterly CFI of OBIO is $557.00 K
What is the all time high quarterly CFI for Orchestra BioMed Holdings?
Orchestra BioMed Holdings all-time high quarterly cash flow from investing activities is $33.15 M
What is Orchestra BioMed Holdings quarterly CFI year-on-year change?
Over the past year, OBIO quarterly cash flow from investing activities has changed by -$12.39 M (-95.70%)
What is Orchestra BioMed Holdings TTM cash flow from investing activities?
The current TTM CFI of OBIO is $49.99 M
What is the all time high TTM CFI for Orchestra BioMed Holdings?
Orchestra BioMed Holdings all-time high TTM cash flow from investing activities is $62.38 M
What is Orchestra BioMed Holdings TTM CFI year-on-year change?
Over the past year, OBIO TTM cash flow from investing activities has changed by +$135.83 M (+158.24%)